Study guide

11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy

C-OBE Obstetric Emergencies Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Maternal Assessment, Risk Stratification & Early Warning Systems

1.1 Pre-Existing Medical, Surgical & Obstetric Comorbidities in Emergency Risk Stratification 1.2 Dynamic Antepartum & Intrapartum Risk Assessment 1.3 Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment 1.4 Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness

2 Chapter 2: Obstetric Hemorrhage — Etiology, Assessment & Uterotonics

2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL) 2.2 Uterotonic Pharmacology & Stepwise Administration Protocols 2.3 Tranexamic Acid (TXA) Protocols & Hemorrhage Timing

3 Chapter 3: Obstetric Hemorrhage — Mechanical Interventions, Placental Disorders & Transfusion

3.1 Intrauterine Tamponade Balloons, Compression Sutures & Surgical Hemostasis 3.2 Ectopic Pregnancy, Placenta Previa, Accreta Spectrum (PAS), Abruption & Vasa Previa 3.3 Obstetric DIC, Coagulopathy & Massive Transfusion Protocol (MTP)

4 Chapter 4: Hypertensive Disorders of Pregnancy & Preeclampsia with Severe Features

4.1 Classification & Spectrum of Hypertensive Disorders of Pregnancy 4.2 Preeclampsia with Severe Features: Pathophysiology & End-Organ Damage 4.3 Diagnostic Evaluation, Laboratory Triggers & Fetal Surveillance in Preeclampsia

5 Chapter 5: Hypertensive Crisis, Eclampsia & Magnesium Sulfate Therapy

5.1 Acute Severe Hypertension & First-Line Antihypertensive Protocols 5.2 Eclampsia Recognition, Seizure Management & Airway Protection 5.3 Magnesium Sulfate Neuroprotection/Seizure Prophylaxis Protocols, Monitoring & Toxicity Reversal 5.4 HELLP Syndrome & Hepatic Crisis Management

6 Chapter 6: Maternal Resuscitation, Cardiac Arrest & Perimortem Cesarean

6.1 Maternal ACLS Modifications & Cardiopulmonary Resuscitation Physiology 6.2 Etiologies of Maternal Arrest & Structured Emergency Response 6.3 Perimortem Cesarean Delivery (PMCD / Resuscitative Hysterotomy)

7 Chapter 7: Amniotic Fluid Embolism & Maternal Shock States

7.1 Amniotic Fluid Embolism (AFE): Pathophysiology & Clinical Presentation 7.2 A-OK Protocol, Hemodynamic Support & Critical Care in AFE 7.3 Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive

8 Chapter 8: Acute Intrapartum Delivery Emergencies

8.1 Shoulder Dystocia: Recognition, Timing & Primary HELPERR Sequence 8.2 Advanced Shoulder Dystocia Maneuvers & Neonatal Brachial Plexus Injury Prevention 8.3 Umbilical Cord Prolapse Recognition & Emergent Decompression Protocols

9 Chapter 9: Uterine Inversion, Malpresentation & Obstetric Trauma

9.1 Acute Uterine Inversion: Recognition, Tocolysis & Manual/Surgical Reduction 9.2 Emergency Vaginal Breech Extraction & Head Entrapment Maneuvers 9.3 Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage

10 Chapter 10: Maternal Sepsis, Intraamniotic Infection & Severe Infections

10.1 Maternal Sepsis: Physiological Criteria, S.O.S. Score & omSOFA 10.2 The Maternal Sepsis Hour-1 Bundle & Fluid/Vasopressor Optimization 10.3 Intraamniotic Infection (Triple I / Chorioamnionitis) & Severe Endometritis 10.4 Severe Pyelonephritis, Maternal Pneumonia & Severe Peripartum Infections

11 Chapter 11: Endocrine, Cardiovascular, Respiratory & Neurologic Emergencies

11.1 Diabetic Ketoacidosis (DKA), Maternal Hypoglycemia & Endocrine Resuscitation in Pregnancy 11.2 Peripartum Cardiomyopathy (PPCM), Acute Heart Failure, Acute Coronary Syndromes & Maternal Arrhythmias 11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy 11.4 Status Epilepticus, Acute Stroke & Cerebral Venous Sinus Thrombosis (CVST)

12 Chapter 12: Thromboembolism, Hepatorenal Disorders & Toxicologic Emergencies

12.1 Venous Thromboembolism (DVT/PE) Diagnosis, Treatment & Peripartum Anticoagulation 12.2 Acute Fatty Liver of Pregnancy (AFLP / Swansea Criteria) & Acute Kidney Injury 12.3 Peripartum Substance Overdose, Opioid Toxicity & Naloxone Administration

13 Chapter 13: Obstetric Anesthesia Emergencies & Critical Complications

13.1 High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis 13.2 Local Anesthetic Systemic Toxicity (LAST) & 20% Lipid Emulsion Rescue Protocol 13.3 Post-Dural Puncture Headache (PDPH), Epidural Hematoma & Abscess 13.4 Malignant Hyperthermia in Obstetric Anesthesia & Dantrolene Protocol

14 Chapter 14: Professional Practice, Team Communication, Debriefing & Health Equity

14.1 Crisis Resource Management (CRM), TeamSTEPPS & Structured Communication 14.2 Multidisciplinary Emergency Debriefing, Morbidity & Mortality, and Systems Learning 14.3 Perinatal Racial/Ethnic Disparities, Implicit Bias Mitigation & Respectful Maternity Care 14.4 Legal, Ethical, Documentation & EMTALA Standards in Obstetric Emergencies

11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy

Key Takeaways Explain This Topic AI

Normal maternal arterial blood gas in pregnancy exhibits compensated respiratory alkalosis (pH 7.40–7.45, PaCO2 28–32 mmHg, PaO2 100–105 mmHg, HCO3 18–21 mEq/L); therefore, a "normal" non-pregnant PaCO2 of 35 to 40 mmHg in a pregnant asthmatic indicates severe respiratory muscle exhaustion and impending respiratory arrest.

Status asthmaticus in pregnancy requires rapid stepwise pharmacological escalation: continuous nebulized short-acting beta-agonists (albuterol) plus ipratropium bromide, early intravenous systemic corticosteroids (methylprednisolone 60 mg IV Q6H), and IV magnesium sulfate (2 g over 20 min) for refractory bronchospasm.

Non-cardiogenic pulmonary edema during pregnancy is most frequently caused by severe preeclampsia capillary leak, iatrogenic crystalloid fluid overload, or beta-agonist tocolysis (terbutaline); it is differentiated from cardiogenic failure by preserved LV systolic function, low/normal pulmonary capillary wedge pressure (PCWP ≤18 mmHg), and lack of significant NT-proBNP elevation.

In pregnancy-associated ARDS, lung-protective mechanical ventilation is mandatory using low tidal volumes (6 mL/kg predicted body weight based on maternal height) and plateau pressures <30 cmH2O, maintaining maternal oxygenation goals of PaO2 ≥70 mmHg (or SpO2 ≥95%) to preserve transplacental oxygen delivery to the fetus.

Last updated: August 2026

Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy

Acute respiratory failure in pregnancy is a critical emergency that threatens both maternal and fetal survival. Because fetal oxygenation depends entirely on maternal arterial oxygen tension and uteroplacental perfusion, maternal hypoxemia rapidly translates into profound fetal hypoxia, acidosis, and demise. Understanding the physiologic alterations of the respiratory system in pregnancy, mastering stepwise interventions for severe bronchospasm, and executing lung-protective mechanical ventilation are essential competencies in obstetric critical care.

  • 1. Respiratory Physiology of Pregnancy & The "Normal" ABG Trap
  • Maternal Respiratory Adaptations

Progesterone-Mediated Hyperventilation: Elevated progesterone stimulates the central medullary respiratory center, increasing tidal volume by 30% to 50% (with minimal change in respiratory rate), leading to an overall 30% to 50% increase in minute ventilation .

Physiologic Arterial Blood Gas (ABG): The hyperventilation produces a chronic, compensated respiratory alkalosis. Renal bicarbonate excretion compensates by lowering serum bicarbonate to 18–22 mEq/L .

Reduced Functional Residual Capacity (FRC): Diaphragmatic elevation by the gravid uterus reduces FRC by 20% to 30% , reducing maternal oxygen reserve.

Increased Oxygen Consumption: Maternal and fetal metabolic demands elevate total oxygen consumption by 20% to 35% . +---------------------------------------------------------------------------------------------------+

  • | ARTERIAL BLOOD GAS (ABG) INTERPRETATION IN PREGNANCY |
  • | |
  • | PARAMETER NON-PREGNANT ADULT NORMAL PREGNANCY CRITICAL IMPLICATION |
  • | • pH: 7.35 – 7.45 7.40 – 7.45 Maternal target >= 7.30 |
  • | • PaCO2: 35 – 45 mmHg **28 – 32 mmHg** **PaCO2 >=35 mmHg = FAILURE|
  • | • PaO2: 80 – 100 mmHg **100 – 105 mmHg** **PaO2 <70 mmHg = HYPOXIA**|
  • | • Serum HCO3-: 22 – 26 mEq/L 18 – 22 mEq/L Reduced buffering capacity |
  • | • Base Excess: -2 to +2 mEq/L -4 to -2 mEq/L Narrow acidosis buffer |
  • | |
  • | THE "NORMAL" CO2 TRAP: |
  • | • In a non-pregnant adult, a PaCO2 of 40 mmHg is entirely normal. |
  • | • In a pregnant patient experiencing an asthma attack, a **PaCO2 of 38–42 mmHg indicates |
  • | SEVERE ALVEOLAR HYPOVENTILATION, RESPIRATORY MUSCLE EXHAUSTION, AND IMPENDING RESPIRATORY |
  • | ARREST!** This represents acute failure of physiological hyperventilation. |
  • +---------------------------------------------------------------------------------------------------+
  • 2. Status Asthmaticus: Stepwise Pharmacological Escalation

Asthma complicates approximately 4% to 8% of pregnancies. Severe exacerbations (status asthmaticus) can rapidly cause severe maternal hypoxemia and fetal demise. +---------------------------------------------------------------------------------------------------+

  • | STEPWISE ESCALATION FOR SEVERE ASTHMA / STATUS |
  • | |
  • | STEP 1: OXYGENATION & INHALED SHORT-ACTING BETA-2 AGONISTS (SABA) |
  • | • High-flow supplemental O2 via nasal cannula or non-rebreather to maintain **SpO2 >= 95%** |
  • | (or PaO2 >= 70 mmHg) to ensure adequate placental oxygen diffusion. |
  • | • **Albuterol (2.5 to 5 mg nebulized)** every 20 minutes for 3 doses, or **Continuous Albuterol |
  • | Nebulization at 10 to 15 mg/hour**. |
  • | |
  • | STEP 2: INHALED ANTICHOLINERGIC THERAPY |
  • | • **Ipratropium Bromide (0.5 mg nebulized)** combined with albuterol every 20 minutes for 3 doses.|
  • | • Synergistic bronchodilation by blocking parasympathetic bronchoconstriction. |
  • | |
  • | STEP 3: SYSTEMIC INTRAVENOUS CORTICOSTEROIDS (EARLY ADMINISTRATION) |
  • | • **Methylprednisolone 60 mg IV every 6 hours** OR **Hydrocortisone 100 mg IV every 6–8 hours**. |
  • | • Oral alternative: Prednisone 40–60 mg PO daily. |
  • | • Corticosteroids reduce airway mucosal edema, decrease mucus plugging, and upregulate beta-2 |
  • | receptors; systemic steroids are entirely safe in pregnancy and must never be withheld. |
  • | |
  • | STEP 4: INTRAVENOUS MAGNESIUM SULFATE FOR REFRACTOSPASM |
  • | • **Magnesium Sulfate: 2 g IV in 100 mL D5W or NS infused over 20 minutes**. |
  • | • Potent bronchial smooth muscle relaxant via calcium channel blockade and inhibition of |
  • | acetylcholine release at motor endplates; highly effective in severe refractory asthma. |
  • | |
  • | STEP 5: SUBCUTANEOUS ADRENERGIC RESCUE (MORIBUND PATIENT) |
  • | • **Terbutaline 0.25 mg SC every 20 min x 3 doses** OR **Epinephrine 0.3 mg (1:1,000) IM/SC**. |
  • | • Indicated if severe air trapping prevents delivery of inhaled aerosolized nebulizers. |
  • +---------------------------------------------------------------------------------------------------+
  • Indications for Urgent Endotracheal Intubation

PaCO2 ≥ 35–40 mmHg (pseudonormalization or hypercapnia).

Refractory severe hypoxemia (PaO2 < 70 mmHg or SpO2 < 95% despite maximal supplemental O2).

Extreme maternal exhaustion, somnolence, altered mental status, or "silent chest" (absent breath sounds due to critical airflow limitation).

Severe acidemia (pH < 7.20).

The Pregnant Airway: Critical Intubation Rules

Obstetric patients have friable, hypervascular, edematous airway mucosa, increased weight, and larger breasts, making them 8 to 10 times more likely to have a failed intubation than non-pregnant patients.

Use video laryngoscopy , have a difficult airway cart (bougie, supraglottic airway, cricothyrotomy kit) at bedside, choose a smaller endotracheal tube (size 6.0 to 6.5 or 7.0 mm cuffed ETT) , pre-oxygenate with 100% O2, and perform rapid sequence intubation (RSI) with continuous cricoid/laryngeal manipulation.

3. Pulmonary Edema in Pregnancy: Cardiogenic vs Non-Cardiogenic

Pulmonary edema in pregnancy complicates approximately 0.08% of all deliveries, but occurs in up to 3% to 5% of women with severe preeclampsia . +---------------------------------------------------------------------------------------------------+

  • | ETIOLOGICAL CLASSIFICATION OF PULMONARY EDEMA |
  • | |
  • | 1. NON-CARDIOGENIC PULMONARY EDEMA (CAPILLARY LEAK / ONCOTIC FAILURE): |
  • | • Preeclampsia / Eclampsia: Severe generalized endothelial dysfunction, increased capillary |
  • | permeability, and severe hypoalbuminemia (colloid oncotic pressure drops from 22 to <14). |
  • | • Tocolytic-Induced: Beta-2 agonists (terbutaline, ritodrine) induce fluid retention, |
  • | exacerbated by concurrent crystalloid hydration and antenatal corticosteroids. |
  • | • Iatrogenic Fluid Overload: Massive IV crystalloid hydration during labor or pre-hydration |
  • | prior to epidural placement; oxytocin infusions in large volumes of hypotonic fluids |
  • | (oxytocin has intrinsic ADH-like antidiuretic properties). |
  • | • Sepsis / Chorioamnionitis / Pyelonephritis: Inflammatory cytokine-mediated capillary injury.|
  • | |
  • | 2. CARDIOGENIC PULMONARY EDEMA (HYDROSTATIC FAILURE): |
  • | • Peripartum cardiomyopathy, severe preeclamptic afterload crisis / hypertensive emergency, |
  • | uncorrected severe mitral stenosis, aortic valve disease, or acute myocardial infarction. |
  • +---------------------------------------------------------------------------------------------------+
  • Diagnostic Differentiation Table

Diagnostic Parameter Non-Cardiogenic Pulmonary Edema Cardiogenic Pulmonary Edema

Left Ventricular Ejection Fraction Normal / Hyperdynamic (LVEF > 55%) Depressed (LVEF < 45%) or severe diastolic dysfunction

  • Pulmonary Capillary Wedge Pressure Normal or Low ( PCWP <= 18 mmHg ) Elevated ( PCWP > 18 mmHg )
  • Serum NT-proBNP / BNP Normal or mildly elevated Markedly elevated (>1,000–5,000 pg/mL)
  • Colloid Oncotic Pressure (COP) Markedly reduced (<15 mmHg) Normal or slightly reduced

Lung Ultrasound (POCUS) Bilateral diffuse B-lines (interstitial syndrome) Bilateral B-lines with pleural effusions & dilated IVC

Emergency Management of Pulmonary Edema

Positioning & Supplemental Oxygen: Place the patient in an upright sitting position. Administer high-flow oxygen; apply Non-Invasive Positive Pressure Ventilation (CPAP 5–10 cmH2O or BiPAP) to increase alveolar recruitment, reduce work of breathing, and decrease venous return (preload) and afterload.

Loop Diuretics: Furosemide 20 to 40 mg IV push (may repeat at 40–80 mg IV at 1 hour if urine output remains inadequate). Indicated for both cardiogenic failure and hypervolemic non-cardiogenic edema.

Vasodilators (for Hypertensive Pulmonary Edema): Intravenous Nitroglycerin (start at 10–20 mcg/min, titrate up to 100–200 mcg/min) or Nicardipine infusion (5 to 15 mg/h). Rapidly reduces preload and afterload.

Strict Fluid Restriction: Limit total fluid intake to <80 to 100 mL/hour .

4. Acute Respiratory Distress Syndrome (ARDS) in Pregnancy

ARDS is a devastating syndrome of non-cardiogenic pulmonary edema, severe alveolar-capillary barrier disruption, and refractory hypoxemic respiratory failure. +---------------------------------------------------------------------------------------------------+

  • | BERLIN CRITERIA FOR ARDS IN PREGNANCY |
  • | |
  • | 1. TIMING: Acute onset within 1 week of a known clinical insult or new/worsening symptoms. |
  • | 2. CHEST IMAGING: Bilateral opacities on chest radiography or CT not fully explained by |
  • | effusions, lobar collapse, or pulmonary nodules. |
  • | 3. ORIGIN OF EDEMA: Respiratory failure not fully explained by cardiac failure or fluid overload. |
  • | 4. OXYGENATION DERANGEMENT (on PEEP >= 5 cmH2O): |
  • | • **Mild ARDS:** 200 mmHg < PaO2 / FiO2 <= 300 mmHg. |
  • | • **Moderate ARDS:** 100 mmHg < PaO2 / FiO2 <= 200 mmHg. |
  • | • **Severe ARDS:** PaO2 / FiO2 <= 100 mmHg. |
  • +---------------------------------------------------------------------------------------------------+
  • Obstetric Triggers for ARDS

Amniotic Fluid Embolism (AFE): Sudden anaphylactoid activation and catastrophic pulmonary vasoconstriction.

Severe Sepsis: Sepsis secondary to chorioamnionitis, septic abortion, acute pyelonephritis, or necrotizing fasciitis.

Massive Hemorrhage & Transfusion: Transfusion-Related Acute Lung Injury (TRALI) and Transfusion-Associated Circulatory Overload (TACO).

Aspiration Pneumonitis (Mendelson Syndrome): Aspiration of acidic gastric contents during emergency anesthesia.

Lung-Protective Mechanical Ventilation Protocol +---------------------------------------------------------------------------------------------------+

  • | LUNG-PROTECTIVE VENTILATION PARAMETERS IN PREGNANCY |
  • | |
  • | 1. TIDAL VOLUME (LOW TIDAL VOLUME VENTILATION): |
  • | • Set Tidal Volume (Vt) to **6 mL/kg of Predicted Body Weight (PBW)** (range 4 to 8 mL/kg). |
  • | • **CALCULATE PBW BASED ON MATERNAL HEIGHT, NOT ACTUAL PREGNANT WEIGHT!** |
  • | - Female PBW (kg) = 45.5 + 0.91 * [Height (cm) - 152.4]. |
  • | - Using actual pregnant weight results in massive volumetric barotrauma (volutrauma). |
  • | |
  • | 2. AIRWAY PRESSURES: |
  • | • Target **Plateau Pressure (Pplat) < 30 cmH2O** (measured during an inspiratory hold). |
  • | • Maintain Driving Pressure (Pplat - PEEP) < 15 cmH2O. |
  • | |
  • | 3. PEEP TITRATION: |
  • | • Titrate PEEP between **8 and 16 cmH2O** using the ARDSNet PEEP/FiO2 titration grid to |
  • | prevent end-expiratory alveolar collapse (atelectotrauma). |
  • | |
  • | 4. OXYGENATION & BLOOD GAS TARGETS: |
  • | • **Maternal PaO2 Target: >= 70 mmHg (or SpO2 95% to 98%)**. |
  • | - Unlike non-pregnant ARDS (where PaO2 55–80 mmHg / SpO2 88–92% is acceptable), pregnancy |
  • | demands higher maternal oxygenation to maintain the transplacental oxygen gradient. |
  • | • **Ventilatory Target (PaCO2): 32 to 40 mmHg**. |
  • | - Avoid severe maternal alkalosis (PaCO2 <28 mmHg), which causes uterine artery vasoconstriction|
  • | and impairs fetal oxygen unloading (Bohr effect). |
  • | - Permissive hypercapnia is allowed cautiously, keeping arterial pH > 7.20 to 7.25. |
  • +---------------------------------------------------------------------------------------------------+
  • Prone Positioning in Obstetric ARDS

Efficacy: In moderate-to-severe ARDS (PaO2/FiO2 <150), prone positioning for ≥16 hours per day significantly improves ventilation-perfusion matching, promotes dorsal alveolar recruitment, and reduces mortality.

Pregnancy Execution: Prone ventilation is feasible and safe in all trimesters . Proper positioning requires positioning rolls or specialized padded bolsters beneath the upper chest/shoulders and pelvis to fully suspend the gravid uterus, avoiding aortocaval compression and direct pressure on the fetus.

Loading diagram... Obstetric Acute Respiratory Failure & ARDS Management Ladder